Sosei Heptares Operational Highlights and Consolidated

Tokyo, Japan and Cambridge, UK, 12 May 2023 – Sosei Group Corporation (“the Company”; TSE: 4565) provides an update on operational activities and reports...

Related Keywords

Tokyo ,Japan ,United Kingdom ,Cambridge ,Cambridgeshire ,Genentech Roche ,Neurocrine Biosciences ,Maya Bennison ,Sosei Heptare ,Tempero Bio ,Candelle Chong ,Hironoshin Nomura ,Shinichiro Nishishita ,Chris Cargill ,Eleanor Perkin ,Frazer Hall ,Sosei Heptares ,Management Team ,Sosei Group Corporation The Company ,Twitter ,Linkedin ,Sosei Group Corporation ,Youtube ,Centessa Pharmaceuticals ,Novartis ,Global Regulatory Affairs At Bristol Myers Squibb ,Astrazeneca ,Tokyo Stock Exchange ,Sosei Group ,Pfizer ,Medistrava Consulting For International Media ,Growth Market ,Prime Market ,Tokyo Stock Price Index ,Executive Management Team ,Keiko Tomita ,Global Regulatory Affairs ,Bristol Myers Squibb ,Senior Vice President ,Corporate Strategy ,Annual Shareholder ,Three Month Period ,Chief Financial Officer ,International Media ,Japan Exchange Group Soltf ,Biotech ,Inance ,Pcr ,